G protein-coupled receptor 120 signaling regulates ghrelin secretion in vivo and in vitro.
Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, is produced predominantly in the stomach. It has been reported that endogenous ghrelin levels are increased by fasting and decreased immediately after feeding and that fasting-induced ghrelin release is controlled by the sympathetic nervous system. However, the mechanisms of plasma ghrelin decrement after feeding are poorly understood. Here, we studied the control of ghrelin secretion using ghrelin-producing cell lines and found that these cells express high levels of mRNA encoding G-protein coupled receptor 120 (GPR120). Addition of GW-9508 (a GPR120 chemical agonist) and α-linolenic acid (a natural ligand for GPR120) inhibited the secretion of ghrelin by ∼50 and 70%, respectively. However, the expression levels of preproghrelin and ghrelin O-acyltransferase (GOAT) mRNAs were not influenced by GW-9508. In contrast, the expression levels of prohormone convertase 1 were decreased significantly by GW-9508 incubation. Moreover, we observed that the inhibitory effect of GW-9508 on ghrelin secretion was blocked by a small interfering RNA (siRNA) targeting the sequence of GPR120. Furthermore, pretreatment with GW-9508 blocked the effect of the norepinephrine (NE)-induced ghrelin elevation in ghrelin cell lines. In addition, we showed that GW-9508 inhibited ghrelin secretion via extracellular signal-regulated kinase activity in ghrelin cell lines. Finally, we found that GW-9508 decreased plasma ghrelin levels in mice. These results suggest that the decrease of ghrelin secretion after feeding is induced partially by long-chain fatty acids that act directly on gastric GPR120-expressing ghrelin cells.
Area of Regulatory Biology, Division of Life Science, Graduate School of Science and Engineering, Saitama University, Shimo-ohkubo, Sakuraku, Saitama, Japan;
Zhi
Z
Gong
Makoto
M
Yoshimura
Sayaka
S
Aizawa
Reiko
R
Kurotani
Jeffrey M
JM
Zigman
Takafumi
T
Sakai
Ichiro
I
Sakata
D000818:Animals; D002460:Cell Line; D045744:Cell Line, Tumor; D005227:Fatty Acids / Q000494:pharmacology; D005502:Food; D005753:Gastric Mucosa / Q000378:metabolism; D054439:Ghrelin / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009638:Norepinephrine / Q000494:pharmacology; D045664:Proprotein Convertase 1 / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D034741:RNA, Small Interfering / Q000494:pharmacology; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D013270:Stomach / Q000737:chemistry; D013274:Stomach Neoplasms / Q000378:metabolism; D017962:alpha-Linolenic Acid / Q000494:pharmacology
C498007:FFAR4 protein, mouse; D005227:Fatty Acids; D054439:Ghrelin; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D043562:Receptors, G-Protein-Coupled; D017962:alpha-Linolenic Acid; D045664:Proprotein Convertase 1; D009638:Norepinephrine
G protein-coupled receptor 120; ghrelin; ghrelin cell line; secretion